| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3284612 | Clinical Gastroenterology and Hepatology | 2010 | 10 Pages |
Abstract
Certolizumab pegol effectively maintains remission of Crohn's disease for up to 18 months. Continuous therapy is more effective than interrupted therapy.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Gastroenterology
Authors
Gary R. Lichtenstein, Ole Ã. Thomsen, Stefan Schreiber, Ian C. Lawrance, Stephen B. Hanauer, Ralph Bloomfield, William J. Sandborn, Precise 3 Study Investigators Precise 3 Study Investigators,